Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies

by Cristian Scatena, Daniela Murtas, Sara Tomei
Published 2021-05-01

Special Issue: Molecular Biomarkers in Solid Tumors

by Nicola Fusco, Caterina Marchiò, Michele Ghidini, Cristian Scatena
Published 2021-06-01

Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization

by Giuseppe Nicolò Fanelli, Antonio Giuseppe Naccarato, Cristian Scatena
Published 2020-04-01

Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method

by Cinzia Mazzini, Pamela Pinzani, Francesca Salvianti, Cristian Scatena, Milena Paglierani, Francesca Ucci, Mario Pazzagli, Daniela Massi
Published 2014-02-01

Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies

by Giuseppe Nicolò Fanelli, Dario Grassini, Valerio Ortenzi, Francesco Pasqualetti, Nicola Montemurro, Paolo Perrini, Antonio Giuseppe Naccarato, Cristian Scatena
Published 2021-03-01

Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro

by Cristian Scatena, Sara Franceschi, Maria Franzini, Chiara Sanguinetti, Nadia Romiti, Laura Caponi, Mario Mandalà, Chiara Maria Mazzanti, Antonio Giuseppe Naccarato
Published 2019-08-01

New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes

by Cristian Scatena, Giovanni Fanelli, Giuseppe Nicolò Fanelli, Michele Menicagli, Paolo Aretini, Valerio Ortenzi, Sara Piera Civitelli, Lorenzo Innocenti, Federica Sotgia, Michael P. Lisanti, Antonio Giuseppe Naccarato
Published 2021-02-01

Molecular characterization of low grade and high grade bladder cancer.

by Alessandro Apollo, Valerio Ortenzi, Cristian Scatena, Katia Zavaglia, Paolo Aretini, Francesca Lessi, Sara Franceschi, Sara Tomei, Carlo Alberto Sepich, Paolo Viacava, Chiara Maria Mazzanti, Antonio Giuseppe Naccarato
Published 2019-01-01

Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study

by Cristian Scatena, Manuela Roncella, Manuela Roncella, Antonello Di Paolo, Paolo Aretini, Michele Menicagli, Giovanni Fanelli, Carolina Marini, Chiara Maria Mazzanti, Matteo Ghilli, Federica Sotgia, Michael P. Lisanti, Antonio Giuseppe Naccarato
Published 2018-10-01

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

by Marco La Ferla, Francesca Lessi, Paolo Aretini, Davide Pellegrini, Davide Pellegrini, Sara Franceschi, Elena Tantillo, Elena Tantillo, Michele Menicagli, Ivo Marchetti, Claudia Scopelliti, Prospero Civita, Claudia De Angelis, Lucrezia Diodati, Ilaria Bertolini, Manuela Roncella, Liam A. McDonnell, Jacob Hochman, Marzia Del Re, Cristian Scatena, Antonio G. Naccarato, Andrea Fontana, Chiara M. Mazzanti
Published 2019-06-01